Home>>Lipids>> Prenol Lipids>>trans,trans-Farnesyl pyrophosphate ammonium salt

trans,trans-Farnesyl pyrophosphate ammonium salt (Synonyms: trans,trans-Farnesyl pyrophosphate ammonium salt)

Catalog No.GC43653

Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway and used in the biosynthesis of terpenes, terpenoids, and sterols.

Products are for research use only. Not for human use. We do not sell to patients.

trans,trans-Farnesyl pyrophosphate ammonium salt Chemical Structure

Cas No.: 116057-57-9

Size Price Stock Qty
250μg
$94.00
In stock
500μg
$180.00
In stock
1mg
$339.00
In stock
5mg
$1,508.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway and used in the biosynthesis of terpenes, terpenoids, and sterols. It also serves as a donor in post-translational isoprenylation of proteins. FPP has been identified as an antagonist of P2Y12 receptors (IC50 = 45 μM), attenuating platelet aggregation. It has also been shown to regulate adipocyte function as an endogenous PPARγ agonist. Additionally, because of a flexible hydrocarbon chain that enables different conformations, FPP is a promiscuous ligand for a subset of nuclear receptors.

Reviews

Review for trans,trans-Farnesyl pyrophosphate ammonium salt

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for trans,trans-Farnesyl pyrophosphate ammonium salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.